For Immediate Release – Xspire Pharma Files Utility Patent for Pharmaceutical Formulation

November 15, 2013
Xspire Pharma, a privately held pharmaceutical company, has filed a utility patent as a follow up to its provisional patent application, for the active ingredients (isometheptene mucate, caffeine, and acetaminophen) in combination with each other. The filing is based on the formulation of active ingredients together in a solid dosage form, based on certain percentages, and intended for oral consumption. Xspire Pharma currently holds a patent pending status for this formulation but is excited about its chances to receive an issued patent number from the USPTO. “We have worked diligently with the best patent team to make this a reality and look forward to the completed review and issue of our patent,” said Ford Mundy.

Legal Disclaimer:
It may take two or more years for the USPTO to review your application and determine whether to issue the patent. An issued patent starts protecting your invention as of its filing date with the USPTO. If you have filed a Provisional Application for Patent relating to the same invention, and your Non-Provisional Utility Patent Application is filed within 12 months of your Provisional Application, your filing date will be the filing date of your Provisional Application. If granted, legal action will be taken from patent issue date, back to the date of provisional patent application.